expert roundtables by David N. Franz, MD; Gary W. Mathern, MD; and Elizabeth A. Thiele, MD, PhD
Epilepsy is the most common neurologic manifestation of TSC, affecting 80% to 90% of patients with the disease, with high rates of treatment resist......READ MORE
clinical topic updates by Elizabeth A. Thiele, MD, PhD
Although tuberous sclerosis complex (TSC) can affect virtually any organ in the body, a great deal of the morbidity in patients with the genetic di......READ MORE
clinical topic updates by Elizabeth A. Thiele, MD, PhD
Tuberous sclerosis complex (TSC) is a rare, multisystem, genetic disorder resulting from mutations in TSC1 and TSC2. Genetic testing may be helpful......READ MORE
clinical topic updates by Elizabeth A. Thiele, MD, PhD
The early identification of tuberous sclerosis complex (TSC) allows for the early implementation of interventions and careful monitoring that may h......READ MORE
Tuberous sclerosis complex (TSC) is a rare, multisystem, genetic disease with variable disease features that may include benign brain tumors, seizu......READ MORE
Tuberous sclerosis complex (TSC) is a complex genetic disease that is remarkably heterogeneous in its manifestations. Seizure freedom, the level of......READ MORE
